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Abstract
Objective: Idiopathic trigeminal neuralgia (TN) is characterized by paroxysms of severe facial pain but without the major
sensory loss that commonly accompanies neuropathic pain. Since neurovascular compression of the trigeminal nerve root
entry zone does not fully explain the pathogenesis of TN, we determined whether there were brain gray matter
abnormalities in a cohort of idiopathic TN patients. We used structural MRI to test the hypothesis that TN is associated with
altered gray matter (GM) in brain areas involved in the sensory and affective aspects of pain, pain modulation, and motor
function. We further determined the contribution of long-term TN on GM plasticity.
Methods: Cortical thickness and subcortical GM volume were measured from high-resolution 3T T1-weighted MRI scans in
24 patients with right-sided TN and 24 healthy control participants.
Results: TN patients had increased GM volume in the sensory thalamus, amygdala, periaqueductal gray, and basal ganglia
(putamen, caudate, nucleus accumbens) compared to healthy controls. The patients also had greater cortical thickness in
the contralateral primary somatosensory cortex and frontal pole compared to controls. In contrast, patients had thinner
cortex in the pregenual anterior cingulate cortex, the insula and the orbitofrontal cortex. No relationship was observed
between GM abnormalities and TN pain duration.
Conclusions: TN is associated with GM abnormalities in areas involved in pain perception, pain modulation and motor
function. These findings may reflect increased nociceptive input to the brain, an impaired descending modulation system
that does not adequately inhibit pain, and increased motor output to control facial movements to limit pain attacks.
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Introduction
Idiopathic trigeminal neuralgia (TN) is a chronic neuropathic
pain disorder characterized by recurring highly intense electric
shock-like pain in the distribution of one or more branches of the
trigeminal nerve. The pain is usually unilateral, occurring either
spontaneously or precipitated by innocuous sensory stimuli and
movements. Although some sensory abnormalities have been
reported in TN using detailed quantitative sensory testing [1,2],
there is typically no major sensory loss detectable with bedside
clinical tests, as observed in other neuropathic pains [1,3]. For
example, in a large multi-center study examining somatosensory
abnormalities in different neuropathic pain syndromes, typical
sensory abnormalities in TN were mechanical hyperalgesia
without sensory loss; an uncommon combination in all other
syndromes examined [1].
Many theories have been proposed to explain the unique pain
characteristics of idiopathic TN. In general, theories of TN focus
on either central or peripheral nervous system pathogenesis [4].
Given that patients with TN are typically initially responsive to
anticonvulsant medications, it has been suggested that the pain
paroxysms characteristic of TN originate in the central nervous
system and are analogous to epileptic seizures in brainstem
trigeminal structures [4,5]. Alternatively, proponents of a periph-
eral etiology suggest that TN results from damage to the trigeminal
nerve or its myelin, with the most prevalent theory proposing
neurovascular compression of the trigeminal nerve root entry zone
(REZ) by a nearby arterial branch [3]. Although neurovascular
contact (NVC) or compression of the trigeminal nerve is frequently
observed, a significant number of idiopathic TN cases do not
demonstrate clear evidence of neurovascular compression [6]. As
the putative pathogenesis of TN is unique, so are its clinical
features. While tumors or other structural abnormalities can result
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in the perception of a trigeminal neuropathic pain, characterized
by persistent pain and sensory changes, idiopathic TN patients are
mostly pain-free between attacks and without major sensory
abnormalities [7]. Since NVC or compression alone does not fully
explain this unique syndrome, central abnormalities may signif-
icantly contribute to TN pain [8,9].
Patients with chronic pains other than TN can show abnormal
gray matter (GM) in brain regions associated with pain and its
modulation, sensory-discriminative and cognitive-affective dimen-
sions of pain, emotion, and motor function [10,11,12,13], the
latter of which may be related to alterations in muscular activity
aimed at limiting movements to protect the system from further
injury and support healing [14,15]. Therefore, GM abnormalities
may reflect maladaptive plasticity arising from long-term pain
and/or nociceptive input to the brain [16], impaired pain
modulation [17], and/or compensatory/nocifensive motor behav-
iors to avoid triggering pain [15]. Importantly, while most chronic
pain syndromes are also accompanied by prominent sensory
deficits, TN is predominantly characterized by pain, but not major
sensory loss [1]. This provides a unique window to our
understanding of how pain impacts central GM. GM abnormal-
ities may be dynamic, progressive, and pain-driven over time
[10,12,18]. Based on the described studies and in consideration of
the unique features of neuropathic pain in TN, we hypothesized
that compared to healthy controls TN patients would have GM (i)
increases in areas associated with pain perception and emotion
(e.g., thalamus, primary and secondary somatosensory cortex (S1,
S2), amygdala, anterior and mid-cingulate cortex (ACC; MCC),
insula and prefrontal cortex (PFC), (ii) decreases in areas associated
with pain modulation (e.g., periaqueductal gray (PAG)), (iii)
increases in motor regions (e.g., primary motor cortex (M1), basal
ganglia), and (iv) abnormalities that progress due to pain
chronicity.
Methods
Ethics Statement
The University Health Network Research Ethics Board
approved this retrospective study of idiopathic TN patients. There
was no active participation in this study by patients, as patient data
were analyzed retrospectively. Additionally our Research Ethics
Board provides study approval, but does not require individual
patient consent for retrospective studies. All scans were anon-
ymized prior to analysis and stored in secure databases.
Recruitment of healthy control subjects and the procedure
whereby their consent was obtained was also approved by the
University Health Network Research Ethics Board. Each healthy
control participant provided written informed consent.
Participants
Twenty-four right-handed idiopathic TN patients from the
Toronto Western Hospital seen between May 2008 and February
2011 were included in the study. Inclusion criteria were: (1)
unilateral (right-sided) pain involving at least the maxillary or
mandibular (V2 or V3) branches of the trigeminal nerve, (2)
intense, sharp, superficial or stabbing paroxysmal facial pain
precipitated from trigger areas or by trigger factors; stereotyped
attacks for each patient; no clinically evident neurological or
sensory deficit or not attributed to another disorder [19], and (3)
no previous surgical procedures for TN. Demographic and clinical
details for patients were obtained via retrospective chart reviews.
Patients were sex-matched to a cohort of 24 healthy pain-free
control participants and the mean ages between the groups were
not statistically different (p=0.81, see results). At the individual
level, all but 2 control participants were within 3 years of the
patients.
Imaging Protocol
Brain imaging data were acquired using a 3T GE Signa HDx
MRI system fitted with an eight-channel phased array head coil.
T1-weighted 3D FSPGR axial images were obtained from the top
of the head to the upper cervical levels of C1–C2
(0.960.961.0 mm3 voxels derived from a 2566256 matrix and
field of view of 24 cm (controls) or 22 cm (patients), echo
time= 5 ms, repetition time= 12 ms, inversion time= 300 ms).
Cortical Thickness Analysis
To examine cortical GM, cortical thickness analysis (CTA) was
performed using FreeSurfer software v. 4.5.0 (http://surfer.nmr.
mgh.harvard.edu/); methods have been described in detail
elsewhere [20]. Briefly, T1-weighted scans were registered to the
Talairach atlas [21]. Images underwent intensity normalization to
identify tissue types, and the skulls were removed. White matter
(WM) voxels were used to estimate the GM/WM boundary, which
was deformed outward to the GM/cerebrospinal fluid (CSF)
boundary. Thickness was computed as the distance measured
Figure 1. Analyses were restricted to gray matter masks. CTA
and VBM gray matter analyses were restricted to masks. (A–D) Cortical
thickness masks for the left (A & B) and right (C & D) hemispheres,
including lateral (A & C) and medial (B & D) views. (E–G) VBM masks of
subcortical structures in coronal (E), sagittal (F) and axial (G) views.
doi:10.1371/journal.pone.0066340.g001
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between these boundaries at every point in each hemisphere. A
general linear model (GLM) was used to evaluate group
differences, with age included as a variable of no interest. We
restricted analyses to a mask including our hypothesized regions of
interest (ROI) (Fig. 1A–D) created with a predefined cortical
parcellation scheme (aparc2005) implemented in FreeSurfer [22].
Data were smoothed with a 6 mm full-width half-maximum
(FWHM) spatial smoothing kernel, and thresholded at a corrected
p,0.05 (from a combination of an uncorrected image-wide p-value
of 0.01, and a cluster threshold of 183 and 188 contiguous vertices
for left and right hemispheres, respectively, based on Monte Carlo
simulations with 5000 iterations (AlphaSim, implemented in
Analysis of Functional NeuroImages (AFNI) (http://afni.nimh.
nih.gov/afni), as done previously [10,12,23].
Voxel-Based Morphometry
To examine subcortical GM group differences, we used voxel-
based morphometry (VBM) [24] in FMRIB’s Software Library v.
4.1.8 (http://www.fmrib.ox.ac.uk/fsl/). Non-brain tissues were
removed from structural images using the Brain Extraction Tool
(BET) [25]. Tissue-type segmentation classified tissue using
FMRIB’s Automated Segmentation Tool (FAST4) [26]. The
GM-classified tissue was aligned to the Montreal Neurologic
Institute (MNI) 152 standard 2 mm template (voxel si-
ze = 26262 mm) using a linear registration tool [27]. Images
were averaged creating a study-specific template, to which GM
images were non-linearly re-registered. Jacobian modulation
allowed group differences in GM to be reported as normalized
volumes. The modulated images were then smoothed with an
isotropic Gaussian kernel with a sigma of 2 mm
(FWHM=4.6 mm). Using the Harvard-Oxford subcortical struc-
tural atlas, a mask was constructed to restrict analyses to the
thalamus, amygdala, hippocampus, basal ganglia, and brainstem
(Fig. 1E–G). A voxelwise GLM was applied with age as a variable
of no interest. Statistical significance was determined using
permutation-based non-parametric testing and thresholded at
p,0.05 using Randomise, implemented in FSL, corrected for
multiple comparisons with threshold-free cluster enhancement
[28]. For consistency with the CTA, VBM results were converted
from MNI to Talairach coordinates using the Yale Nonlinear
MNI to Talairach Conversion Algorithm [29] implemented on the
BioImage Suite 2.0 website (http://www.bioimagesuite.org/
Mni2Tal/).
We performed a secondary analysis to determine if prolonged
nociceptive activity (i.e., pain duration) was related to GM
changes. In this analysis, TN duration was treated as a regressor
of interest. Analyses were restricted to the CTA and VBM masks
described above. The same statistical correction methods were
used to determine significant correlations between GM and pain
duration.
Table 1. TN Patient Demographic Information.
Patient Sex Age Pain Dist Pain Duration (years) Age at Pain Onset Medication
R1 F 45 V2 10 35 CBZ
R2 M 67 V2, V3 8 59 CBZ
R3 F 62 V3 11 51 CBZ, PGB
R4 F 68 V2, V3 3 65 CBZ, GBP
R5 M 52 V1, V2 5 47 CBZ
R6 F 44 V2, V3 2 42 None
R7 F 55 V2 6 49 None
R8 F 40 V2 10 30 CBZ
R9 M 50 V1, V2, V3 6.5 44 –
R10 F 63 V2 8 55 CBZ
R11 M 47 V3 5 42 CBZ, PGB
R12 F 52 V3 5 47 CBZ, VPA, TCA
R13 F 55 V2, V3 2 53 CBZ, GBP
R14 F 41 V1, V2, V3 7 34 CBZ
R15 M 24 V2 4 20 CBZ
R16 M 37 V3 1 36 CBZ, PGB
R17 M 24 V3 2 22 CBZ, TCA-N
R18 M 38 V2 2 36 CBZ
R19 F 42 V2, V3 2 40 CBZ, GBP
R20 F 52 V1, V2 3 49 CBZ
R21 F 27 V2, V3 13 14 CBZ, GBP
R22 F 56 V3 6 50 CBZ
R23 M 62 V1, V2, V3 3 59 PGB
R24 F 60 V2 6 54 CBZ
Note: – indicates information not available.
Abbreviations: Pain Dist: pain distribution, referring to the peripheral branches of the trigeminal nerve (V1: ophthalmic branch; V2: maxillary branch; V3: mandibular
branch); CBZ: carbamazepine; PGB: pregabalin; GBP: gabapentin; TCA: tricyclic antidepressant; VPA: valproic acid; TCA-N: nortriptyline;
doi:10.1371/journal.pone.0066340.t001
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Results
Patient Demographics
Patient demographic information is shown in Table 1. The TN
group (n= 24) was comprised of 15 women and 9 men (mean age
6 SD: 48.5612.7 years) who had right-sided TN pain for 6.363.0
years with a mean age at pain onset of 43.0612.9 years. The
majority of patients were on medications for TN at the time of
scan acquisition, with the most common being carbamazepine
(Table 1). The healthy control group consisted of 15 women and 9
men with a mean age 6 SD of 47.6612.3 years, which was not
significantly different (p=0.81) from the patient group.
Regions of Abnormal Cortical Thickness in TN Patients
All CTA results are provided in Table 2 and prominent findings
are illustrated in Figure 2. Compared to controls, TN patients had
14–16% greater cortical thickness within three regions: the left
(contralateral to side of pain) S1 including the putative face area
(Fig. 2D, inferior S1 cluster), frontal pole (FP) (BA 10) bilaterally,
and M1 bilaterally. CTA also revealed several cortical regions that
were 10–19% thinner compared to controls. The most prominent
areas of thinning were located bilaterally in the pregenual ACC
(pgACC) (BA 24) and the ventral orbitofrontal cortex (OFC) (BA
11) (Fig. 2A & C). Cortical thinning was also observed in the right
dorsal posterior insula (dpINS), ventral anterior insula (aINS)
(Fig. 2B), and posterior cingulate cortex (PCC).
Larger Subcortical Volumes in TN Patients
Subcortical regions that had significantly different GM volumes
in the TN patients compared to controls are listed in Table 3.
Although the ventral pons had significantly less GM volume in the
TN group compared to controls, for all other subcortical regions
that were significantly different between groups, patients had
larger volumes. The TN group had greater GM volumes than
controls bilaterally in the several thalamic regions that spanned the
medial dorsal (MD) nucleus, the ventral posteromedial (VPM)
nucleus (Fig. 3A), the pulvinar, and the ventral lateral (VL)
nucleus. The TN group also had greater GM than controls in the
right amygdala (Fig. 3B), an increase of 13%, and in a cluster
spanning the nucleus accumbens (NAc), caudate, and anterior
putamen (19% increase) (Fig. 3C). Bilaterally, a substantially
greater volume of the posterior putamen (average increase of 38%)
and in the PAG (increase of 27%) (Fig. 3D & E) was observed in
the TN group compared to the control group.
No Correlation between Gray Matter Abnormalities and
Pain Duration
TN pain duration was not significantly related to cortical
thickness or subcortical volume for any region within the CTA and
VBM masks, nor within areas of GM abnormality when
specifically examined (p.0.05).
Figure 2. Cortical thickness abnormalities in trigeminal neu-
ralgia patients. CTA revealed significant group differences in several
cortical brain regions. Red clusters indicate thinner cortex in patients
compared to controls (p,0.05, corrected). Prominent findings of
cortical thinning in TN are shown in panels A–C, including graphs of
mean cortical thickness values 6 SEM (in mm): controls (black bars),
patients (red bars). Areas of cortical thickening in TN are highlighted in
panel D. Thinner cortex in TN was observed in: (A) the bilateral pgACC;
graph illustrates thickness for left cluster; (B) the right insular cortex
including the dpINS and the ventral aINS, and (C) the bilateral ventral
OFC; graph illustrates thickness for right OFC cluster. TN patients had
thicker cortex in (D) the bilateral FP and M1, and contralateral (left) S1;
graphs illustrate thickness for right FP cluster and the inferior S1 cluster
(putative face area). Abbreviations: LH= left hemisphere; RH= right
hemisphere; R = right; L = left; pgACC= pregenual anterior cingulate
cortex; PCC= posterior cingulate cortex; aINS = anterior insula; dpINS=
dorsal posterior insula; OFC= orbitofrontal cortex; FP = frontal pole;
M1= primary motor cortex; S1 = primary somatosensory cortex.
doi:10.1371/journal.pone.0066340.g002
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Discussion
In this study, we provide novel evidence that TN, a neuropathic
pain thought to arise from a peripheral event, characterized
primarily by pain and the absence of major sensory loss is
associated with pronounced alterations in brain GM. These
abnormalities occur in neuroanatomical regions that contribute to
sensory-discriminative and cognitive-affective dimensions of pain,
pain modulation, and motor function. Specifically, we identified
that compared to controls, TN patients have: (1) greater GM in
the thalamus, contralateral S1 (putative face area), amygdala, FP,
PAG, M1, and basal ganglia (including the putamen and NAc),
and (2) cortical thinning in the OFC, pgACC, and insula.
Abnormalities in these brain regions have been reported in other
chronic pain disorders [13]. However, in previous studies, the
contributions of sensory loss and pain are often intertwined. Our
findings raise the possibility that the CNS contributes to the
development and/or maintenance of TN pain and help advance
our knowledge of how a peripheral event is associated with central
gray changes.
Potential mechanisms underlying MR-detectable GM differ-
ences have been broadly divided into two categories: neuronal and
non-neuronal mechanisms, including alterations in vasculature,
the size or numbers of glia and/or dendritic spines/branches
[30,31]. Evidence for the activity-dependent alteration of these
structures has been demonstrated as a result of experience and
learning, with the majority of studies reporting non-neuronal
mechanisms as the primary contributor to GM differences in
regions outside of the hippocampus [31]. GM abnormalities in TN
patients may also occur via these mechanisms, elicited by
experience-dependent factors such as changes in nociceptive input
to the CNS, affect, and learned compensatory/nocifensive motor
behaviors. Alternatively, it is possible that some individuals are
more susceptible to developing chronic pain because of pre-
existing GM abnormalities [13]. This possibility cannot explicitly
be tested in a cross-sectional study. In the current study, we did not
find any evidence to support this possibility based on assessing
disease duration-related GM abnormalities. However, we cannot
totally rule out the contribution of some pre-existing functional or
structural vulnerability as was found in other chronic pain studies
[13,32].
Consistent with our a priori hypothesis, we found that TN
patients had more GM in the thalamic nuclei compared to
controls. Although we included patients with only right-sided pain,
the greater thalamic volume was found bilaterally. This bilateral
finding is in line with a previous functional MRI study on TN
patients that showed bilateral thalamic activity when unilateral
stimuli were used to evoke pain attacks [33]. Also, certain thalamic
neurons, including MD neurons, have been shown to have large,
bilateral receptive fields [34], which may in part account for this
finding. Previous studies of chronic facial pain have reported
mixed findings with regard to patient thalamic volume relative to
controls [11,12,18]. This variability may be due to the heteroge-
neity of pain symptomology between chronic facial pains [35]. For
example, patients with trigeminal neuropathic pain have constant
pain accompanied by numbness [36]. Indeed, one study examin-
ing different chronic facial pains found that only trigeminal
neuropathy patients had significantly smaller thalamic volume
compared to controls [11]. It is possible that this difference reflects
a system that is steadily receiving nociceptive, but not discrimi-
native touch input, fitting with trigeminal neuropathy symptomol-
ogy. However, a barrage of nociceptive input, in combination with
mostly intact discriminative touch sensations (i.e., no numbness),
may induce GM increases in the medial and lateral thalamic
nuclei of TN patients. Similarly, this theory may account for our
finding of a thicker putative face S1 in TN. The barrage of
nociceptive input to the thalamus from the trigeminal nerve may
in turn lead to activity-dependent plasticity in S1 [37] via
Table 2. Cortical Thickness Abnormalities in TN.
Hemis Region BA Peak Coordinates (TAL) # Vert Peak T-Score % Change
Change (cf.
Controls)
X Y Z
Right (ipsi) FP 10 29 53 211 770 9.12 16.0 incr
OFC 11 14 20 213 418 4.86 217.2 decr
pgACC 24 8 29 29 203 2.57 213.2 decr
PCC 23 7 239 30 305 2.85 29.5 decr
S. temp 42 39 231 12 295 3.55 212.3 decr
dpINS 32 220 16 362 4.46 212.9 decr
aINS 41 210 212 206 3.15 212.3 decr
M1 4 25 213 64 205 3.32 12.1 incr
Left (contra) FP 10 232 52 211 680 6.59 15.8 incr
OFC 11 214 20 214 490 6.38 219.3 decr
pgACC 24 210 32 210 261 3.41 218.8 decr
S. temp 42 240 232 7 232 5.50 212.6 decr
S1 2 254 217 34 232 3.68 15.5 incr
S1 1 247 219 55 400 4.06 14.2 incr
MI 4 235 211 55 223 4.06 13.7 incr
Abbreviations: TN: trigeminal neuralgia; Hemisp: hemisphere; BA: Brodmann Area; TAL: Talairach; # Vert: number of vertices; ipsi: ipsilateral to side of pain; contra:
contralateral to side of pain; GM: gray matter; OFC: orbitofrontal cortex; PCC: posterior cingulate cortex; pgACC: pregenual anterior cingulate cortex; S. temp: superior
temporal cortex; MI: primary motor cortex; S1: primary somatosensory cortex; FP: frontal pole; dpINS: dorsal posterior insula; aINS: anterior insula; % Change: percent
thickness change; Change cf. Controls: direction of change compared to controls.
doi:10.1371/journal.pone.0066340.t002
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thalamocortical projections. Indeed, repeated noxious stimulation
in healthy individuals can increase S1 GM volume [38]. With pain
chronicity, thicker S1 cortex, particularly of the contralateral
putative face region, may reflect enhanced intensity and localiza-
tion of nociceptive information from the face. Increased S1 GM
has previously been reported in chronic pain disorders involving
the trigeminal system including migraine, temporomandibular
disorder (TMD), and trigeminal neuropathic pain [12,39,40].
We further observed that TN patients had thinner cortex in the
pgACC, aINS, and OFC compared to controls, a finding that has
been reported in numerous chronic pain conditions [13]. These
regions have been implicated in aspects of the cognitive-affective
dimension of pain as well as other functions including attention,
salience, interoception, and top-down mechanisms such as placebo
analgesia, and pain modulation [17]. The pgACC is thought to
contribute to pain unpleasantness, salience, and the regulation of
emotional information [13], while the aINS has been implicated in
salience as well as pain intensity and anticipation, and negative
emotions such as anxiety [41]. The role of the OFC includes
sensory, pain, and emotion regulation [42]. Less GM in these
regions may then reflect the high degree of pain unpleasantness
and/or emotional responses to TN or chronic pain in general, as
similar findings have been reported in several chronic pain
populations [13].
The mechanism of pain-related cortical thinning is not yet
established. One possibility, as described in other patient
populations, is that there are focal losses of cortical inhibitory
interneurons, making these regions hyperactive [43]. In the
chronic pain literature, evidence to support alterations in cortical
inhibition comes from studies using transcranial magnetic
stimulation (TMS) on patients with chronic pain [44]. By applying
magnetic pulses to the cortex of chronic pain patients and
measuring peripheral muscle activity, TMS studies have demon-
strated changes in cortical inhibition mediated by gamma
aminobutyric acid (GABA) receptors [44]. Although these studies
have focused on the motor cortex, it is possible that similar
mechanisms are taking place in other cortical regions and will be
an avenue of future research [44]. An alternate explanation is that
thinner cortex reflects pruning due to use-dependent synapse
elimination, as associated with the development of cognitive
abilities and behavior [45]. Thus, thinner cortex in these regions
could indicate an enhanced or more efficient system for processing
the affective dimension of pain.
Interestingly, the FP was thicker in TN patients; a finding also
reported in TMD [12]. The precise function of the FP is not well
understood, but it has been implicated in a number of complex
cognitive functions including multitasking, monitoring, and
evaluating expected outcomes [46]. It is possible that the thicker
cortex in the FP may occur because there is a greater cognitive
load associated with having TN. Future behavioral studies are thus
needed to determine the role of cognitive factors on the structural
abnormalities reported in the current study.
Similar to findings in migraine [47], another paroxysmal pain
disorder, we report greater PAG volume in TN patients. It has
been proposed that the descending pain modulatory system is
altered in chronic pain such that there is either dysfunction in
nociceptive inhibition, or enhancement in nociceptive facilitation
Figure 3. Regions of greater subcortical volume in patients
with trigeminal neuralgia. VBM analysis revealed significant group
differences in several subcortical brain regions. Significant results
(p,0.05, corrected) are displayed on the MNI152 (2 mm) T1 brain
template. Blue clusters indicate greater GM volume in patients
compared to controls. Graphs of normalized GM volumes 6 SEM are
shown to the right of brain images: controls (black bars), patients (red
bars). Increased patient GM volume was observed in: (A) the sensory
thalamus, including the MD and VPM thalamus bilaterally; (B) the right
amygdala; (C) a cluster spanning the right nucleus accumbens, anterior
putamen and caudate; (D) the posterior putamen bilaterally; (E) the
PAG (green box shows magnified region). Abbreviations: R = right; L =
left; MD= medial dorsal nucleus (thalamus); VPM= ventral posterior
medial nucleus (thalamus); NAc = nucleus accumbens; PAG= periaq-
ueductal gray.
doi:10.1371/journal.pone.0066340.g003
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[17]. Previous animal research has shown that PAG stimulation
inhibits trigeminal nociceptive signals, suggesting that PAG
abnormalities may lead to the disinhibition of trigeminal afferents
[48]. Greater PAG volume may reflect activity-dependent
increases in modulation because the system is ineffective at
inhibiting nociceptive signals, or because there is a need to
counter-balance the barrage of nociceptive input from the
trigeminal nerve. Additionally, pain modulation can be influenced
by several psychological factors such as attention, emotion,
placebo, and anticipation via connections to cortical regions
including the ACC, insula, and PFC and subcortical regions such
as the amygdala [17]. This combined with a larger PAG volume
may reflect differences in the psychological modulation of TN
pain. In our study, we show these regions to be abnormal in TN
patients. Additionally, and consistent with our results, there is
right-lateralized noxious-evoked amygdala activity, possibly relat-
ed to the emotional response to pain and pain modulation [49].
Although evidence for pain-related lateralization is controversial,
right hemispheric lateralization using functional neuroimaging
techniques has also been documented in several brain areas,
regardless of the side of stimulation [50].
Consistent with our hypothesis, we report increased GM in
motor regions. One characteristic of TN is that normally non-
painful movements can elicit attacks of pain, so some patients
attempt to restrict facial movements. This restriction has been
observed in other facial pains such as TMD [15]. The Pain
Adaptation Model [14,15] proposes a framework for nocifensive
behaviors. Specifically, pain leads to alterations in muscular
activity aimed at limiting movements of an affected muscle by
redistributing function and load. In the short term, this protects
the system from further injury to support healing, but prolonged
muscular alteration can lead to more pain and further peripheral
damage. Greater GM volumes in these structures may represent
compensatory/nocifensive strategies employed by TN patients to
prevent and/or decrease their pain. Since facial movements such
as talking and chewing are characteristically bilateral, the bilateral
putamen and motor thalamus findings may represent bilateral
compensatory motor behaviours. Additionally, larger basal ganglia
volumes have been reported bilaterally in patients with migraine,
an interesting finding given that migraine pain, like TN, can be
paroxysmal involving the trigeminal nerve [51]. Importantly, M1
findings may also reflect alterations to the motor root of the
trigeminal nerve and/or abnormal pain modulation, given the use
of motor cortex stimulation as a treatment for neuropathic pain
[52].
Some basal ganglia structures that were larger in TN patients
have also been implicated in non-motor functions. For example,
evidence suggests a role for the putamen in the sensory aspects of
pain [53]. TN patients also had larger NAc volumes, which may
reflect greater efforts to evaluate ongoing pain and/or predict
future outcomes regarding pain [54].
Some previous studies of chronic pain have found correlations
between pain duration and brain GM [10,12], suggesting that long
term pain drives neuroplasticity [38]. We did not find evidence for
this relationship in our TN patients. However, TN is quite
different since it consists of repetitive paroxysmal pain rather than
the sustained ongoing pain characteristic of other neuropathic
pains. Additionally, TN patients are heterogeneous with regard to
the number of pain attacks they have per day, and thus the use of
pain duration may not be an adequate index of total pain over
time for the purposes of assessing pain-driven brain changes in this
patient group. Future longitudinal studies are needed to explore
this factor.
Additionally, nearly all of our patients were taking medication
for TN, with the most common being the anticonvulsant,
carbamazepine. Although the precise impact of these medications
on brain morphology is not known, it is possible that they
influence structural abnormalities. Future studies are needed to
examine the effects of these drugs on brain GM.
Taken together, our study demonstrates for the first time, that
patients with idiopathic TN have prominent GM abnormalities in
brain regions involved in sensory-discriminative and cognitive-
affective dimensions of pain, pain modulation, and motor function.
Unlike other facial pains, TN patients have paroxysmal pain,
frequently triggered by innocuous stimuli, and are without major
sensory loss. The GM abnormalities reported in the current study
likely reflect this unique symptomology. Understanding the
contribution of central GM abnormalities in this population is a
crucial step towards elucidating the mechanisms underlying this
unique neuropathic pain.
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Table 3. Subcortical Volume Abnormalities in TN.
Region Peak Coordinates (TAL) # Voxels Peak T-Score % Change
Change (cf.
Controls)
X Y Z
Thalamus 5 29 3 518 5.52 18.4 incr
R NAc/Caud/Putamen 7 5 25 89 4.83 18.6 incr
L Post. Putamen 227 219 8 64 7.42 41.2 incr
R Post Putamen 29 221 5 60 5.00 34.2 incr
R Amygdala 23 25 212 19 4.92 13.2 incr
PAG 4 233 26 19 5.93 27.3 incr
Pons 9 226 234 561 4.49 284.9 decr
Abbreviations: TN: trigeminal neuralgia; TAL: Talairach;# Voxels: number of voxels; R: right; L: left; NAc: nucleus accumbens; Post: posterior; PAG: periaqueductal gray; %
Change: percent thickness change; Change cf. Controls: direction of change compared to controls.
Note- voxel size for VBM analysis = 26262 mm.
doi:10.1371/journal.pone.0066340.t003
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